Literature DB >> 7088192

Cells regulate their mitogenic response to thrombin through release of protease nexin.

D A Low, R W Scott, J B Baker, D D Cunningham.   

Abstract

We previously reported that human and mouse fibroblast-like cells release into their growth medium a protein that we termed protease nexin. Protease nexin forms a covalent acyl linkage with thrombin and certain other serine proteases via the protease active site and mediates their binding, internalization and degradation by cells. Binding of thrombin-protease nexin to cells is mediated by the protease nexin portion of the complex to a high-affinity cellular binding site. As thrombin is a potent mitogen for a variety of fibroblast-like cells in culture, we examined whether protease nexin itself regulates thrombin-stimulated cell division. Recently, we showed that heparin virtually blocked the binding of thrombin-protease nexin complexes to both mouse and human cells without affecting the ability of these cells to respond to thrombin. Thus, protease nexin does not appear to be a positive modulator in thrombin-induced cell division. Here, we show that protease nexin negatively regulates the mitogenic response of cells in culture to thrombin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7088192     DOI: 10.1038/298476a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  13 in total

1.  Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.

Authors:  J D Weber; D M Raben; P J Phillips; J J Baldassare
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

2.  Differential dependence of early and late increases in 1,2-diacylglycerol on the presence of catalytically active alpha-thrombin: evidence for regulation at the level of 1,2-diacylglycerol generation.

Authors:  L A Rangan; T M Wright; D M Raben
Journal:  Cell Regul       Date:  1991-04

Review 3.  Thrombin in inflammation and healing: relevance to rheumatoid arthritis.

Authors:  R Morris; P G Winyard; D R Blake; C J Morris
Journal:  Ann Rheum Dis       Date:  1994-01       Impact factor: 19.103

4.  Activation of phospholipase D by alpha-thrombin or epidermal growth factor contributes to the formation of phosphatidic acid, but not to observed increases in 1,2-diacylglycerol.

Authors:  T M Wright; S Willenberger; D M Raben
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

5.  Sustained increase in 1,2-diacylglycerol precedes DNA synthesis in epidermal-growth-factor-stimulated fibroblasts. Evidence for stimulated phosphatidylcholine hydrolysis.

Authors:  T M Wright; H S Shin; D M Raben
Journal:  Biochem J       Date:  1990-04-15       Impact factor: 3.857

6.  Thrombin perturbs neurite outgrowth and induces apoptotic cell death in enriched chick spinal motoneuron cultures through caspase activation.

Authors:  V L Turgeon; E D Lloyd; S Wang; B W Festoff; L J Houenou
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

7.  Effect of thrombin on maturing human megakaryocytes.

Authors:  E M Cramer; J M Massé; J P Caen; I Garcia; J Breton-Gorius; N Debili; W Vainchenker
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

8.  Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I.

Authors:  B L Bergman; R W Scott; A Bajpai; S Watts; J B Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Dual coupling of the alpha-thrombin receptor to signal-transduction pathways involving phosphatidylinositol and phosphatidylcholine metabolism.

Authors:  J Cheng; J J Baldassare; D M Raben
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

10.  Human fibroblasts accelerate the inhibition of thrombin by protease nexin.

Authors:  D H Farrell; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.